                         SEQUENCE LISTING

<110>  MICROBIOTIX, INC.
       Bowlin, Terry L
       Peet, Norton P.
       Butler, Michelle M
       Cardinale, Steven C
       Li, Bing
       Pai, Ramdas
 
<120>  INHIBITORS OF BOTULINUM NEUROTOXINS

<130>  MBX-308.2 PCT

<150>  US 61/274,809
<151>  2009-08-21

<150>  US 61/320,268
<151>  2010-04-01

<150>  US 61/375,694
<151>  2010-08-20

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  substrate for fluorescence reaction


<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  N-(2,4-dinitrophenyl) lysine (DnpK)

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  3-iodoacetamido-4-methyl-7-dimethylamino coumarin cycsteine 
       (daciaC)

<400>  1

Ser Asn Arg Thr Arg Ile Asp Glu Ala Asn Lys Arg Ala Cys Arg Met 
1               5                   10                  15      


Leu 
    


<210>  2
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  substrate for a fluorescence reaction


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  N-terminal lysine modified: 7-methoxycoumarin-4-yl acetyl lysine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  N-(2,4-dinitrophenyl)lysine (DnpK)

<220>
<221>  MOD_RES
<222>  (10)..(10)
<223>  AMIDATION

<400>  2

Lys Lys Val Tyr Pro Tyr Pro Met Glu Lys 
1               5                   10  


